Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GFOD2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | DLX2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RELT | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | CDKAL1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | GMPR | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | FRYL | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TSPO2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TBKBP1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ZBED4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
mRNA | NPIPA1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |